Allon Therapeutics, Inc. Appoints Chief Medical Officer for Expanding Clinical Program

May 21, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

VANCOUVER, BRITISH COLUMBIA--(Marketwire - May 21, 2008) - Allon Therapeutics Inc. (TSX:NPC) announced today the appointment of J. Steven Whitaker, M.D., J.D. as Vice President, Clinical Development and Chief Medical Officer of the Company.

Twitter
LinkedIn
Facebook
Email
Print

People